Immune Activation and HIV Persistence

Current Opinion in HIV and AIDS - United States
doi 10.1097/coh.0b013e32835f9788
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Immune Activation and HIV

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2016English

HIV-associated Chronic Immune Activation

Immunological Reviews
AllergyImmunology
2013English

Immune Activation With HIV Vaccines

Science
MultidisciplinaryPhilosophy of ScienceHistory
2014English

Inflammation, Immune Activation, and Cardiovascular Disease in HIV

AIDS
Infectious DiseasesAllergyImmunology
2016English

Editorial: HIV-Associated Immune Activation and Persistent Inflammation

Frontiers in Immunology
AllergyImmunology
2019English

Microbial Translocation and Microbiome Dysbiosis in HIV-associated Immune Activation

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2016English

TLR7/9 Antagonist Reduces HIV-1-induced Immune Activation

Retrovirology
VirologyInfectious Diseases
2012English

Immune Persistence After Pertussis Vaccination

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2017English

Reduction of Immune Activation With Chloroquine Therapy During Chronic HIV Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy